Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome

Li J, Zhou DB, Huang Z, et al.

Blood · 2011

Grade Bcohortn=31
DOI ↗PubMed ↗

Key Findings

  • ●Hematologic response 80.6% (CR 38.7%, PR 41.9%)
  • ●Neurologic response 100%
  • ●Pulmonary hypertension resolved in 93.3%
  • ●Low toxicity profile

Referenced in (1 disease)

POEMS Syndrome
ID: pmid-21393478DOI: 10.1182/blood-2010-12-328112PMID: 21393478